Reply To: Covid 19 Vaccine

The Food and Drug Administration is reportedly expected to administer a new warning on the Johnson & Johnson COVIDC-19 vaccine and a possible link to Guillain-Barré, a rare autoimmune nerve disorder.

The Washington Post, citing four individuals familiar with the matter, said the warning is expected after about 100 cases of Guillain-Barré occurred against a backdrop of nearly 12.8 million Johnson & Johnson vaccine recipients. The Post reported the cases occurred about two weeks post-vaccination, mostly among men, with many aged over 50.